within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10A_InsulinsAndAnalogues.A10AB06_InsulinGlulisine;

model InsulinGlulisine
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C(
    weight = 70,
    F = 1,
    Cl = 3.333333333333333e-07,
    adminDuration = 600,
    adminMass = 0.15 / 1000000,
    adminCount = 1,
    Vd = 0.0126,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>InsulinGlulisine</td></tr><tr><td>ATC code:</td><td>A10AB06</td></tr><td>route:</td><td>subcutaneous</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>0.15</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>12.6</td><td>L</td></tr>
    <tr><td>clearance:</td><td>1.2</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Insulin glulisine is a rapid-acting insulin analogue used in the management of diabetes mellitus for the control of blood glucose. It is administered to mimic the prandial (meal-time) insulin peak and is approved for use in both type 1 and type 2 diabetes. Currently, it is an approved and commonly used medication for insulin therapy.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers following subcutaneous administration.</p><h4>References</h4><ol><li><p>Chao, M, et al., &amp; Ning, G (2010). Bioequivalence between two human insulin analogs in Chinese population: Glulisine and Lispro. <i>Endocrine</i> 38(1) 48–52. DOI:<a href=\"https://doi.org/10.1007/s12020-010-9326-4\">10.1007/s12020-010-9326-4</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/20960101/\">https://pubmed.ncbi.nlm.nih.gov/20960101</a></p></li><li><p>Danne, T, et al., &amp; Rave, K (2005). Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes. <i>Diabetes care</i> 28(9) 2100–2105. DOI:<a href=\"https://doi.org/10.2337/diacare.28.9.2100\">10.2337/diacare.28.9.2100</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/16123473/\">https://pubmed.ncbi.nlm.nih.gov/16123473</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.A.A10AB06 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end InsulinGlulisine;
